Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
FAM53A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MSTN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IRX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ELOVL6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TIA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCNJ2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRRC46 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SV2B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC400748 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ASB4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928449 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MEIS3P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NPL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
B3GALT5-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MMRN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NETO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TCERG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HDAC9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on